3D Systems (DDD) Proxy filing summary

Executive summary

• Annual Meeting scheduled for May 14, 2026, to be held virtually, with voting on key proposals and director elections.

• Company focused on innovation, restructuring, and cost reduction amid macroeconomic challenges, with continued investment in R&D and targeted strategies for Healthcare and Industrial Solutions.

• Significant progress made in remediating material weaknesses in internal controls, with expectation to complete remediation in 2026.

• Board reduced overall debt and repositioned maturities to strengthen financial resilience.

Voting matters and shareholder proposals

• Election of nine directors for one-year terms, all current directors, including exceptions for age and prior voting outcomes.

• Advisory vote on executive compensation for 2025 (say-on-pay).

• Ratification of Deloitte & Touche LLP as independent auditor for 2026.

• Approval to amend Certificate of Incorporation to increase authorized common shares from 220M to 440M.

• Approval to amend and restate the 2015 Incentive Plan, adding 4M shares and extending the term to 2036.

Board of directors and corporate governance

• Board consists of nine nominees, eight of whom are independent; diverse backgrounds and skills matrix provided.

• Board leadership is separated from CEO role; Chair is an independent director.

• Board refreshment includes term limits and retirement age, with exceptions made for valuable expertise.

• Annual self-evaluations and director stock ownership requirements in place.

• Four standing committees: Audit, Compensation, Compliance/Corporate Governance/Sustainability, and Technology Applications.